Scheer, Rowlett & Associates Investment Management Ltd. / CRC
Scheer, Rowlett & Associates Investment Management Ltd.’s Canadian Nat Res Ltd Med Ter Position
Does Scheer, Rowlett & Associates Investment Management Ltd. own Canadian Nat Res Ltd Med Ter (CRC)? Yes — 762.0K shares worth $37M (+2.67% of its 13F portfolio) as of Q1 2026, down from 791.8K shares the prior filed quarter.
Position Value
$37M
Q1 2026
Shares
762.0K
% of Portfolio
+2.67%
Quarters Held
30
currently held
Position History CRC
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 762.0K | $37M | +2.67% |
| Q4 2025 | 791.8K | $27M | +1.84% |
| Q3 2025 | 956.1K | $31M | +1.82% |
| Q2 2025 | 938.4K | $30M | +1.91% |
| Q1 2025 | 917.2K | $28M | +2.09% |
| Q4 2024 | 890.6K | $27M | +2.00% |
| Q3 2024 | 878.3K | $29M | +2.03% |
| Q2 2024 | 889.4K | $32M | +2.43% |
| Q1 2024 | 446.1K | $34M | +2.52% |
| Q4 2023 | 447.1K | $29M | +2.21% |
| Q3 2023 | 455.3K | $29M | +2.48% |
| Q2 2023 | 463.0K | $26M | +2.08% |
| Q1 2023 | 449.1K | $25M | +2.06% |
| Q4 2022 | 452.3K | $25M | +2.10% |
| Q3 2022 | 457.9K | $21M | +1.92% |
| Q2 2022 | 473.7K | $25M | +2.02% |
| Q1 2022 | 492.3K | $30M | +2.00% |
| Q4 2021 | 498.6K | $21M | +1.45% |
| Q3 2021 | 521.3K | $19M | +1.35% |
| Q2 2021 | 515.1K | $19M | +1.35% |
| Q1 2021 | 521.4K | $16M | +1.24% |
| Q4 2020 | 671.6K | $16M | +1.25% |
| Q3 2020 | 913.8K | $15M | +1.29% |
| Q2 2020 | 1.66M | $29M | +2.61% |
| Q1 2020 | 1.57M | $22M | +2.17% |
| Q4 2019 | 1.63M | $53M | +3.88% |
| Q3 2019 | 2.23M | $59M | +4.59% |
| Q2 2019 | 2.46M | $66M | +4.55% |
| Q1 2019 | 2.43M | $67M | +4.65% |
| Q4 2018 | 2.42M | $58M | +4.50% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Scheer, Rowlett & Associates Investment Management Ltd.’s full portfolio or all institutional holders of CRC.